Jiameng is siphoning the money for himself.don’t expect him to do the right thing by shareholders. We have to force his hands.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025